These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17350)

  • 1. Mechanisms of zymogen activation.
    Stroud RM; Kossiakoff AA; Chambers JL
    Annu Rev Biophys Bioeng; 1977; 6():177-93. PubMed ID: 17350
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties of the His57-Asp102 dyad of rat trypsin D189S in the zymogen, activated enzyme, and alpha1-proteinase inhibitor complexed forms.
    Kaslik G; Westler WM; Gráf L; Markley JL
    Arch Biochem Biophys; 1999 Feb; 362(2):254-64. PubMed ID: 9989934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the active center of trypsinogen by comparative affinity chromatography of trypsinogen, alpha-, beta-, psi-trypsins, DIP-trypsin, chymotrypsinogen, alpha-chymotrypsin and elastase.
    Chauvet J; Acher R
    Int J Pept Protein Res; 1974; 6(1):37-41. PubMed ID: 4850322
    [No Abstract]   [Full Text] [Related]  

  • 4. Probes of the mechanism of zymogen catalysis.
    Lonsdale-Eccles JD; Neurath H; Walsh KA
    Biochemistry; 1978 Jul; 17(14):2805-9. PubMed ID: 687564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ala226 to Gly and Ser189 to Asp mutations convert rat chymotrypsin B to a trypsin-like protease.
    Jelinek B; Antal J; Venekei I; Gráf L
    Protein Eng Des Sel; 2004 Feb; 17(2):127-31. PubMed ID: 15047908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sepharose-bound trypsin and activated sepharose-bound trypsinogen. Studies with small and large substrates.
    Knights RJ; Light A
    Arch Biochem Biophys; 1974 Feb; 160(2):277-86. PubMed ID: 4831618
    [No Abstract]   [Full Text] [Related]  

  • 7. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
    Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
    J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited proteolyses in pancreatic chymotrypsinogens and trypsinogens.
    Rovery M
    Biochimie; 1988 Sep; 70(9):1131-5. PubMed ID: 3147704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on subunit III of bovine procarboxypeptidase A. Structure and reactivity of the weakly functional active site.
    Wicker C; Puigserver A
    FEBS Lett; 1981 Jun; 128(1):13-6. PubMed ID: 7274452
    [No Abstract]   [Full Text] [Related]  

  • 10. Catalysis by chymotrypsinogen. Demonstration of an acyl-zymogen intermediate.
    Gertler A; Walsh KA; Neurath H
    Biochemistry; 1974 Mar; 13(6):1302-10. PubMed ID: 4856029
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of ethanol and acetaldehyde on proteolytic enzyme activity of the small intestine and pancreas].
    Skrzydlewska E
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1986-1987; 31-32():19-28. PubMed ID: 3152145
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydrogen bonds in serine proteinases and their complexes with protein proteinase inhibitors. Proton nuclear magnetic resonance studies.
    Markley JL
    Biochemistry; 1978 Oct; 17(22):4648-56. PubMed ID: 569493
    [No Abstract]   [Full Text] [Related]  

  • 13. Attempts to convert chymotrypsin to trypsin.
    Venekei I; Szilágyi L; Gráf L; Rutter WJ
    FEBS Lett; 1996 Mar; 383(1-2):143-7. PubMed ID: 8612781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of chronic ethanol ingestion on the pancreatic proteolytic enzymes and their inhibitors in the rat.
    Jalovaara P; Huttunen R
    Scand J Gastroenterol; 1977; 12(7):785-92. PubMed ID: 563615
    [No Abstract]   [Full Text] [Related]  

  • 15. Catalysis by serine proteases and their zymogens. A study of acyl intermediates by circular dichroism.
    Kerr MA; Walsh KA; Neurath H
    Biochemistry; 1975 Nov; 14(23):5088-94. PubMed ID: 1238107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The isolation and partial characterization of trypsinogen, pancreatic secretory trypsin inhibitor and multiple forms of chymotrypsinogen and trypsin from the pancreas of the ostrich (Struthio camelus).
    Smith N; Naudé RJ; Oelofsen W; Lazure C; Patthy A
    Int J Biochem; 1992 Jun; 24(6):877-85. PubMed ID: 1612178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity.
    Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P
    J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure reveals basis for the inhibitor resistance of human brain trypsin.
    Katona G; Berglund GI; Hajdu J; Gráf L; Szilágyi L
    J Mol Biol; 2002 Feb; 315(5):1209-18. PubMed ID: 11827488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional structure of the complex between pancreatic secretory trypsin inhibitor (Kazal type) and trypsinogen at 1.8 A resolution. Structure solution, crystallographic refinement and preliminary structural interpretation.
    Bolognesi M; Gatti G; Menagatti E; Guarneri M; Marquart M; Papamokos E; Huber R
    J Mol Biol; 1982 Dec; 162(4):839-68. PubMed ID: 7169635
    [No Abstract]   [Full Text] [Related]  

  • 20. The crystal and molecular structure of DIP-inhibited bovine trypsin at2.7Angstrom resolution.
    Stroud RM; Kay LM; Dickerson RE
    Cold Spring Harb Symp Quant Biol; 1972; 36():125-40. PubMed ID: 4508129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.